Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 4036 AL 4050

Apathy Treatment in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial

Rea R, Carotenuto A, Traini E, Fasanaro AM, Manzo V, Amenta F.

J Alzheimers Dis. 2015;48(2):377-83. doi: 10.3233/JAD-141983.

Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study

Gauthier S, Rountree S, Finn B, LaPlante B, Weber E, Oltersdorf T.

J Alzheimers Dis. 2015;48(2):473-81. doi: 10.3233/JAD-150414.

Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease

Samuraki M, Matsunari I, Yoshita M, Shima K, Noguchi-Shinohara M, Hamaguchi T, Ono K, Yamada M.

J Alzheimers Dis. 2015;48(2):517-28. doi: 10.3233/JAD-150274.

Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial

Di Stefano F, Epelbaum S, Coley N, Cantet C, Ousset PJ, Hampel H, Bakardjian H, Lista S, Vellas B, Dubois B, Andrieu S; GuidAge study group.

J Alzheimers Dis. 2015;48(3):793-804. doi: 10.3233/JAD-150013.

Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study

Eriksdotter M, Vedin I, Falahati F, Freund-Levi Y, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Cederholm T, Palmblad J.

J Alzheimers Dis. 2015;48(3):805-12. doi: 10.3233/JAD-150102.

Structural Neuroimaging of the Medial Temporal Lobe in Alzheimer's Disease Clinical Trials

Menéndez-González M, de Celis Alonso B, Salas-Pacheco J, Arias-Carrión O.

J Alzheimers Dis. 2015;48(3):581-9. doi: 10.3233/JAD-150226.

Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS)

Matsuzono K, Sato K, Kono S, Hishikawa N, Ohta Y, Yamashita T, Deguchi K, Nakano Y, Abe K.

J Alzheimers Dis. 2015;48(3):757-63. doi: 10.3233/JAD-150518.

New Perspectives on Alzheimer's Disease and Nutrition

Gustafson DR, Clare Morris M, Scarmeas N, Shah RC, Sijben J, Yaffe K, Zhu X.

J Alzheimers Dis. 2015;46(4):1111-27. doi: 10.3233/JAD-150084.

Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease

Liu-Seifert H, Siemers E, Price K, Han B, Selzler KJ, Henley D, Sundell K, Aisen P, Cummings J, Raskin J, Mohs R; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;47(1):205-14. doi: 10.3233/JAD-142508.

Structure and function of legumain in health and disease

Dall E, Brandstetter H.

Biochimie. 2016 Mar;122:126-50. doi: 10.1016/j.biochi.2015.09.022. Epub 2015 Sep 25.

Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease

Bukhari SN, Jantan I.

Mini Rev Med Chem. 2015;15(13):1110-21. doi: 10.2174/138955751513150923101841.

Physiopathology of Dementia in Iranian Traditional Medicine

Ahmadian-Attari MM, Shirzad M.

J Evid Based Complementary Altern Med. 2016 Oct;21(4):253-4. doi: 10.1177/2156587215607837. Epub 2015 Sep 30.

Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis

Heurling K, Leuzy A, Zimmer ER, Lubberink M, Nordberg A.

Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):362-373. doi: 10.1007/s00259-015-3208-1. Epub 2015 Oct 6.

Stress, Meditation, and Alzheimer's Disease Prevention: Where The Evidence Stands

Khalsa DS.

J Alzheimers Dis. 2015;48(1):1-12. doi: 10.3233/JAD-142766.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias